Inventor · disambiguated record
Neil Roy Curtis
Also filed as: CURTIS NEIL R · CURTIS NEIL ROY
33 granted patents·2 pending applications·724 citations·filing 1992–2006
97Inventor score
Files withMERCK SHARP & DOHME27MERCK SHARPE & DOHME LTD2CURTIS NEIL ROY1MERCH SHARP & DOHME LTD1MERCK & CO INC1
Top patents by PatentIndex Score
35 records- 0194US6172077B1Spiro-azacyclic derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 1998·Granted Jan 9, 2001·149 cites·15 claims
- 0292US5576319APyrrolo-pyridine derivativesMERCK SHARP & DOHME·Filed 1994·Granted Nov 19, 1996·55 cites·30 claims
- 0391US5700809APyrrolo-pyridine derivativesMERCK SHARP & DOHME·Filed 1994·Granted Dec 23, 1997·49 cites·9 claims
- 0490US5432177APyrrolo-pyridine derivativesMERCK SHARPE & DOHME LTD·Filed 1994·Granted Jul 11, 1995·79 cites·6 claims
- 0589US5712285APyrrolo-pyridine derivativesMERCK SHARP & DOHME·Filed 1996·Granted Jan 27, 1998·48 cites·7 claims
- 0686US5952315AUse of NK-1 receptor antagonists for treating bipolar disordersMERCK SHARP & DOHME·Filed 1997·Granted Sep 14, 1999·34 cites·5 claims
- 0782US6319944B1Aryl amidines, compositions containing such compounds and methods of useMERCK & CO INC·Filed 2000·Granted Nov 20, 2001·21 cites·22 claims
- 0881US5563150APyrrolo-pyridine derivativesMERCK SHARP & DOHME·Filed 1995·Granted Oct 8, 1996·27 cites·7 claims
- 0979US6395766B1Tetrahydroindolone derivatives as gabaaalpha5 ligands for enhancing cognitionMERCK SHARP & DOHME·Filed 1999·Granted May 28, 2002·27 cites·7 claims
- 1075US6071928ASpiro-piperidine derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 1997·Granted Jun 6, 2000·21 cites·21 claims
- 1173US5929054AUse of NK-1 receptor antagonists for treating sexual dysfunctionsMERCK SHARP·Filed 1997·Granted Jul 27, 1999·41 cites·3 claims
- 1271US5849765ATetrahydropyridine derivatives as dopamine receptor subtype ligandsMERCK SHARP & DOHME·Filed 1997·Granted Dec 15, 1998·14 cites·8 claims
- 1370US5622950APyrrolo-pyridine derivativesMERCK SHARP & DOHME·Filed 1995·Granted Apr 22, 1997·14 cites·11 claims
- 1468US6727249B2Azabicyclic ether derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 2002·Granted Apr 27, 2004·4 cites·16 claims
- 1567US5977104AUse of NK-1 receptor antagonists for treating bipolar disordersMERCK SHARP & DOHME·Filed 1998·Granted Nov 2, 1999·29 cites·4 claims
- 1667US5700802AFuropyridine derivativesMERCK SHARP & DOHME·Filed 1996·Granted Dec 23, 1997·12 cites·13 claims
- 1765US7094777B25-HT2A receptor ligandsMERK SHARP & DOHME LTD·Filed 2004·Granted Aug 22, 2006·5 cites·24 claims
- 1865US6114315AUse of NK-1 receptor antagonists for treating major depressive disorders with anxietyMERCK SHARP & DOHME·Filed 1998·Granted Sep 5, 2000·26 cites·4 claims
- 1961US5331089APeptides useful as tachykinin agonistsMERCK SHARPE & DOHME LTD·Filed 1992·Granted Jul 19, 1994·18 cites·9 claims
- 2056US6071927ASpiro-piperidine derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 1997·Granted Jun 6, 2000·13 cites·24 claims
- 2148US5925627AUse of NK-1 receptor antagonists for treating movement disordersMERCK SHARP & DOHME·Filed 1997·Granted Jul 20, 1999·7 cites·11 claims
- 2243US7592456B2Arylsulfonylnaphthalene derivatives as 5HT2A antagonistsMERCK SHARP & DOHME·Filed 2005·Granted Sep 22, 2009·0 cites·10 claims
- 2343US7276607B25-HT7 receptor antagonistsMERCK SHARP & DOHME·Filed 2002·Granted Oct 2, 2007·0 cites·8 claims
- 2443US6271230B1Use of NK-1 receptor antagonists for treating cognitive disordersMERCK SHARP & DOHME·Filed 1999·Granted Aug 7, 2001·6 cites·5 claims
- 2543US6100256AUse of NK-1 receptors antagonists for treating schizophrenic disordersMERCK SHARP & DOHME·Filed 1998·Granted Aug 8, 2000·7 cites·11 claims
- 2643US5830901ATetrahydropyridinylmethyl derivatives of pyrrolo 2,3-B!pyridineMERCH SHARP & DOHME LTD·Filed 1995·Granted Nov 3, 1998·7 cites·13 claims
- 2742US2009012134A1Arylsulfonyl Benzofused Heterocycles as 5-Ht2a AntagonistsCURTIS NEIL ROY·Filed 2006·Application pending·0 cites
- 2841US5919781AUse of NK-1 receptor antogonists for treating substance use disordersMERCK SHARP & DOHME·Filed 1997·Granted Jul 6, 1999·5 cites·6 claims
- 2938US6087348AUse of NK-1 receptor antagonists for treating stress disordersMERCK SHARP & DOHME·Filed 1999·Granted Jul 11, 2000·3 cites·15 claims
- 3038US5861407ATetrahydropyridine derivatives as dopamine receptor subtype ligandsMERCK SHARP & DOHME·Filed 1997·Granted Jan 19, 1999·1 cites·6 claims
- 3137US6613766B1Pentaaza-cyclopental[a]naphthalene derivatives as ligands for GABAa α5 receptorsMERCK SHARP & DOHME·Filed 1999·Granted Sep 2, 2003·2 cites·10 claims
- 3237US2003119871A1Amidine derivatives as selective antagonists of ndma receptorsFiled 2001·Application pending·0 cites
- 3333US6613765B1Use of NK-1 receptor antagonists for treating major depressive disordersMERCK SHARP & DOHME·Filed 1998·Granted Sep 2, 2003·0 cites·8 claims
- 3431US6096729AUse of NK-1 receptor antagonists for treating amnestic disordersMERCK SHARP & DOHME·Filed 1997·Granted Aug 1, 2000·0 cites·5 claims
- 3531US5681836AMethanesulfonate salts of antipsychotic benzofuran derivativesMERCK SHARP & DOHME·Filed 1996·Granted Oct 28, 1997·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Neil Roy Curtis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →